论文信息 - Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro. - 字舞流文

Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro.

I. Chourpa | Nicolas Joubert | M. Viaud-Massuard | C. Colas | E. Allard-Vannier | N. Aubrey | Z. Lakhrif | I. Dimier-Poisson | F. Bryden | Camille Martin | Stéphanie Letast | Nils Collinet